Konkuk University Medical Center
Tae-yop Kim, MD PhD
The primary endpoint of this study is the completion time of hemostasis treatment when administered Fresh frozen plasma (FFP) and frozen powder coagulation factor concentrate (PCC) in goal-directed bleeding management for cardiac surgery.
Cardiac Valve Disease
fresh frozen plasma
prothrombin complex concentrate
PHASE4
| Study Type : | INTERVENTIONAL |
| Estimated Enrollment : | 152 participants |
| Masking : | DOUBLE |
| Primary Purpose : | TREATMENT |
| Official Title : | Prothrombin Complex Concentrate and Fresh Frozen Plasma in Viscoelastic Test-based Goal-directed Bleeding Management in Cardiac Surgery |
| Actual Study Start Date : | 2024-03-01 |
| Estimated Primary Completion Date : | 2025-04-01 |
| Estimated Study Completion Date : | 2025-04-01 |
Information not available for Arms and Intervention/treatment
| Ages Eligible for Study: | 20 Years to 75 Years |
| Sexes Eligible for Study: | ALL |
| Accepts Healthy Volunteers: | 1 |
Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.
No Location Found